Curran, H. Valerie
Freeman, Tom P.
Mokrysz, Claire
Lewis, David A.
Morgan, Celia J. A.
Parsons, Loren H.
Article History
First Online: 7 April 2016
Competing interests
: C.J.A.M. has been a consultant for Janssen and GlaxoSmithKline. D.A.L. currently receives investigator-initiated research support from Pfizer and in 2012–2014 served as a consultant in the areas of target identification and validation and new compound development for Autifony, Bristol-Myers Squibb, Concert Pharmaceuticals and Sunovion. H.V.C., T.P.F., C.M. and L.H.P. declare no competing interests.